Xinyan Li

1.3k total citations
37 papers, 917 citations indexed

About

Xinyan Li is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xinyan Li has authored 37 papers receiving a total of 917 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 17 papers in Cancer Research and 16 papers in Oncology. Recurrent topics in Xinyan Li's work include HER2/EGFR in Cancer Research (7 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Ferroptosis and cancer prognosis (5 papers). Xinyan Li is often cited by papers focused on HER2/EGFR in Cancer Research (7 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Ferroptosis and cancer prognosis (5 papers). Xinyan Li collaborates with scholars based in China, France and India. Xinyan Li's co-authors include Yabei Xu, Mingdong Zhou, Mengshen Wang, Xifu Liu, Mozhi Wang, Litong Yao, Haoran Dong, Tie Sun, Xiangyu Sun and Jingyi Guo and has published in prestigious journals such as Journal of the American College of Cardiology, Scientific Reports and Free Radical Biology and Medicine.

In The Last Decade

Xinyan Li

34 papers receiving 909 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinyan Li China 14 519 299 248 190 93 37 917
Hui Xiong China 19 563 1.1× 223 0.7× 101 0.4× 90 0.5× 128 1.4× 41 951
Simone Polvani Italy 19 950 1.8× 212 0.7× 173 0.7× 263 1.4× 86 0.9× 38 1.4k
Jorge Navarro‐Dorado Spain 16 479 0.9× 227 0.8× 412 1.7× 56 0.3× 87 0.9× 30 950
Xin‐Sheng Deng United States 13 600 1.2× 205 0.7× 362 1.5× 64 0.3× 126 1.4× 21 968
Jun Feng China 15 330 0.6× 197 0.7× 165 0.7× 71 0.4× 71 0.8× 43 800
Dennis Sohn Germany 16 739 1.4× 160 0.5× 344 1.4× 82 0.4× 35 0.4× 24 1.1k
Zhengyu Liu China 18 544 1.0× 165 0.6× 219 0.9× 66 0.3× 113 1.2× 60 1.1k
De‐Long Hao China 19 702 1.4× 221 0.7× 104 0.4× 178 0.9× 105 1.1× 37 1.4k
Xiping Xin Canada 12 360 0.7× 153 0.5× 243 1.0× 62 0.3× 74 0.8× 17 776

Countries citing papers authored by Xinyan Li

Since Specialization
Citations

This map shows the geographic impact of Xinyan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinyan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinyan Li more than expected).

Fields of papers citing papers by Xinyan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinyan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinyan Li. The network helps show where Xinyan Li may publish in the future.

Co-authorship network of co-authors of Xinyan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xinyan Li. A scholar is included among the top collaborators of Xinyan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinyan Li. Xinyan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jia, Xutao Zhang, Xinyan Li, et al.. (2025). TRAF7 protects against acute lung injury by promoting K6-linked ubiquitination of AKT. Science Bulletin. 71(3). 510–514.
2.
Li, Miaomiao, Yi Wang, Xinyan Li, et al.. (2025). Pharmacological targeting of the mitochondrial phosphatase PTPMT1 sensitizes hepatocellular carcinoma to ferroptosis. Cell Death and Disease. 16(1). 257–257. 4 indexed citations
3.
Li, Yuxuan, Zhe Piao, Xinyan Li, et al.. (2025). Screening of glycan biomarkers for early detection of colorectal cancer based on novel isotope labeling relative quantitative method. Journal of Pharmaceutical Analysis. 15(11). 101262–101262. 1 indexed citations
4.
Ying, Yang, Xinyan Li, Hua Zhang, et al.. (2025). Targeting the ATM-TRMT10A-BRCA1 axis confers synthetic lethality to PARP inhibition in metastatic castration-resistant prostate cancer. Science Advances. 11(41). eadw7989–eadw7989.
5.
6.
Li, Xinyan, et al.. (2025). The CNC-family transcription factor NRF3: A crucial therapeutic target for cancer treatment. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(5). 167794–167794. 1 indexed citations
7.
Li, Chao, Da Zheng, Kai Jiang, et al.. (2024). Morphological phenotype of right ventricular outflow tract is associated with cardiovascular outcomes and premature death. Scientific Reports. 14(1). 25128–25128.
8.
Guo, Ying, Xinyan Li, Rongrong Liu, et al.. (2024). Gaudichaudione H ameliorates liver fibrosis and inflammation by targeting NRF2 signaling pathway. Free Radical Biology and Medicine. 224. 770–784. 2 indexed citations
9.
Liu, Guoqiang, Quntao Yu, Houze Zhu, et al.. (2023). Amyloid-β mediates intestinal dysfunction and enteric neurons loss in Alzheimer's disease transgenic mouse. Cellular and Molecular Life Sciences. 80(12). 351–351. 8 indexed citations
10.
Li, Xinyan, Yixiao Yuan, Mintu Pal, & Xiulin Jiang. (2022). Identification and Validation of lncRNA-SNHG17 in Lung Adenocarcinoma: A Novel Prognostic and Diagnostic Indicator. Frontiers in Oncology. 12. 929655–929655. 5 indexed citations
11.
12.
Chen, Yuqiong, Li Su, Yan Zhang, et al.. (2021). The lncRNA Malat1 regulates microvascular function after myocardial infarction in mice via miR-26b-5p/Mfn1 axis-mediated mitochondrial dynamics. Redox Biology. 41. 101910–101910. 115 indexed citations
13.
Yao, Litong, Mozhi Wang, Mengshen Wang, et al.. (2021). The choice of a neoadjuvant chemotherapy cycle for breast cancer has significance in clinical practice: results from a population-based, real world study. Cancer Biology and Medicine. 19(5). 755–767. 6 indexed citations
14.
Li, Xinyan, Litong Yao, Mozhi Wang, et al.. (2020). Updated Bayesian Network Meta-Analysis of Adjuvant Targeted Treatment Regimens for Early Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer. Journal of Breast Cancer. 23(4). 410–410. 1 indexed citations
15.
Sun, Xiangyu, Mozhi Wang, Mengshen Wang, et al.. (2020). Role of Proton-Coupled Monocarboxylate Transporters in Cancer: From Metabolic Crosstalk to Therapeutic Potential. Frontiers in Cell and Developmental Biology. 8. 651–651. 53 indexed citations
16.
Liu, Sihong, Jianhua Zhao, Yong Wu, et al.. (2014). Effect of radiation on cytotoxicity, apoptosis and cell cycle arrest of human osteosarcoma MG-63 induced by a ruthenium(II) complex. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 140. 202–209. 12 indexed citations
17.
Gong, Nian, Xinyan Li, Qi Xiao, & Yong‐Xiang Wang. (2013). Identification of a Novel Spinal Dorsal Horn Astroglial d-Amino Acid Oxidase–Hydrogen Peroxide Pathway Involved in Morphine Antinociceptive Tolerance. Anesthesiology. 120(4). 962–975. 30 indexed citations
18.
Liu, Sihong, Qinghua Liu, Jianhua Zhao, et al.. (2012). Cytotoxicity, Apoptosis, Cellular Uptake, Cell Cycle Distribution, and DNA-Binding Investigation of Ruthenium Complexes. DNA and Cell Biology. 31(7). 1205–1213. 9 indexed citations
19.
Xu, Yabei, Xinyan Li, Xifu Liu, & Mingdong Zhou. (2010). Neuregulin-1/ErbB Signaling and Chronic Heart Failure. Advances in pharmacology. 59. 31–51. 36 indexed citations
20.
Gao, Runlin, Jian Zhang, Xue-si Wu, et al.. (2010). A Phase II, Randomized, Double-Blind, Multicenter, Based on Standard Therapy, Placebo-Controlled Study of the Efficacy and Safety of Recombinant Human Neuregulin-1 in Patients With Chronic Heart Failure. Journal of the American College of Cardiology. 55(18). 1907–1914. 212 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hui Xiong Breakdown of academic impact, for papers by Simone Polvani Breakdown of academic impact, for papers by Jorge Navarro‐Dorado Breakdown of academic impact, for papers by Xin‐Sheng Deng Breakdown of academic impact, for papers by Jun Feng Breakdown of academic impact, for papers by Dennis Sohn Breakdown of academic impact, for papers by Zhengyu Liu Breakdown of academic impact, for papers by De‐Long Hao Breakdown of academic impact, for papers by Xiping Xin
Rankless by CCL
2026